product summary
Loading...
company name :
Miltenyi Biotec
product type :
antibody
product name :
CD85h (ILT1) Antibody, anti-human, Biotin, REAfinity™
catalog :
130-100-906
quantity :
30 tests in 300 µL
price :
99 USD
clonality :
monoclonal
host :
human
conjugate :
biotin
clone name :
REA219
reactivity :
human
application :
flow cytometry
more info or order :
citations: 2
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
Chen Y, Gao F, Chu F, Peng H, Zong L, Liu Y, et al. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes. J Mol Biol. 2009;386:841-53 pubmed
|
product information
MB Cataloge Number :
130-100-906
Catalog Number :
130-100-906
Product Name :
CD85h (ILT1) Antibody, anti-human, Biotin, REAfinity™
Product Type :
Primary antibodies, Recombinant antibodies
Host Species :
recombinant human IgG1
Clonality :
monoclonal
Conjugation :
Biotin
Antigen Modification :
CD85h (ILT1)
Clone Name :
REA219
Isotype :
REA Control Antibody (S), human IgG1
Size :
30 tests in 300 µL
US List Price :
99 USD
Product Description :
Identification and enumeration of CD85h (ILT1)+ cells by flow cytometry
ALTnames :
LILRA2, ILT1, LIR-7
Specificity :
human
Concentration :
1:11
Uses :
For research use only
Application Summary :
Flow cytometry
Storage :
Store protected from light at 2–8 °C. Do not freeze.
more info or order :
company information

Miltenyi Biotec
Friedrich-Ebert-Strae 68
51429 Bergisch Gladbach
51429 Bergisch Gladbach
macs@miltenyibiotec.com
https://www.miltenyibiotec.com1 800 FOR MACS
headquarters: Germany
related products
browse more products
- CD85h (ILT1) Antibody, anti-human, Biotin, REAfinity™ | 130-100-912
- CD85k (ILT3) Antibody, anti-human, FITC, REAfinity™ | 130-099-814
- CD85k (ILT3) Antibody, anti-human, FITC, REAfinity™ | 130-099-811
- CD85k (ILT3) Antibody, anti-human, PE, REAfinity™ | 130-099-809
- CD85k (ILT3) Antibody, anti-human, PE, REAfinity™ | 130-099-808
questions and comments